CORRECTION FROM SOURCE: CannaPharmaRx to Host Investor Conference Call

Rhea-AI Summary

CannaPharmaRx (OTC PINK:CPMD) announced an investor conference call on May 21, 2024, at 1 PM EST to discuss recent developments.

CEO Dean Medwid will review the company's financials, product and harvesting updates, purchase orders, inventory and shipments, distributor relations, expansion plans, and forecasted revenues.

The call will be accessible by dialing 530-881-1212 with ID 615-253-385# and Passcode 1674609.

A recording of the call will be available upon request for those unable to attend.

Positive

• Announcement of an investor conference call indicates ongoing communication with shareholders.
• CEO Dean Medwid will provide comprehensive updates on key business areas, fostering transparency.
• Discussion on forecasted revenues might provide insights into future financial performance.
• Updates on product and harvesting could signal progress in operations and potential increases in productivity.
• Information on purchase orders, inventory, and shipments may reflect operational efficiency and demand.

Negative

• No specific financial figures or achievements mentioned in the PR, leaving uncertainty about current performance.
• The updated PR corrects an error from a previous release, which might indicate lapses in communication accuracy.
• The absence of detailed metrics or performance indicators limits the ability to assess the current business health.

CannaPharmaRx to Host Investor Conference Call - Tuesday May 21st, 2024

This updates the previous Press Release that had an incorrect date included

CALGARY, AB / ACCESSWIRE / May 20, 2024 / CannaPharmaRx, Inc. (OTC PINK:CPMD), a future leader in ultramodern, highly efficient cannabis production facilities announced today that it will hold an investor conference call on Tuesday, May 21, 2024, at 1PM Eastern time to give an update on progress.

Chief Executive Officer Dean Medwid will be leading the discussion on various topics including:

• Review of financials and achievements
• Product and harvesting update
• Update on purchase orders, inventory and shipments
• Distributor and expansion update
• Forecasted Revenues

Interested parties can join the conference call by dialing in: When: Tuesday, 05/21/24 at 1:00 pm EST Phone Number: 530-881-1212 ID Pin: 615-253-385#

Passcode:

1674609

For interested individuals unable to join the conference call a recording will be available upon request.

Please visit www.cannapharmarx.com for additional information about our company and products.

About CannapharmaRx, Inc.

CannapharmaRx is focused on the acquisition and development of state-of-the-art cannabis grow facilities in Canada. CPMD is in discussion with other companies regarding potential acquisitions. CannapharmaRx's business strategy is to become a leader in high quality and low-cost production of cannabis through the development, acquisition, and enhancement of existing facilities. CannapharmaRx is committed to operating high-quality facilities utilizing the latest technology in combined heat and power generation to ensure being a low-cost producer of cannabis.

Safe Harbor Statement

Cautionary Note Regarding Forward-Looking Information or Statements

This press release contains forward-looking information or statements. All statements that are or information which is not historical facts, including without limitation, statements regarding future estimates, plans, programs, forecasts, projections, objectives, assumptions, expectations, or beliefs of future performance, are 'forward-looking information or statements.' Forward-looking information or statements can be identified by the use of words such as 'plans,' 'expects,' or 'does not expect,' 'is expected,' 'estimates,' 'intends,' 'anticipates,' or 'does not anticipate,' or 'believes,' or variations of such words and phrases or statements that certain actions, events or results 'may,' 'could,' 'would,' 'might' or 'will' be taken, occur or be achieved. With respect to forward-looking information and statements contained herein, Management of CannapharmaRx has made numerous assumptions, including, among other things, assumptions about general business and economic conditions. Such forward-looking statements are based on assumptions and involve known and unknown risks, uncertainties, and other factors that may cause actual results, events, or developments to be materially different from any future results, events, or developments expressed or implied by such forward-looking information or statements. Readers are cautioned not to place undue reliance on such forward-looking information or statements. There can be no assurance that forward-looking statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in forward-looking information or statements. CannapharmaRx assumes no obligation to update any forward-looking information or statements, even if new information becomes available as a result of future events, new information, or for any other reason except as required by law.

Contact Information:
Brokers and Analysts
Chesapeake Group
(410) 825-3930

SOURCE: CannaPharmaRx

View the original press release on accesswire.com

FAQ

When is the CannaPharmaRx investor conference call?

The investor conference call is on Tuesday, May 21, 2024, at 1 PM EST.

What topics will be discussed in the CannaPharmaRx investor conference call?

The call will cover financial reviews, product and harvesting updates, purchase orders, inventory and shipments, distributor relations, expansion plans, and forecasted revenues.

How can I join the CannaPharmaRx investor conference call?

Interested parties can join by dialing 530-881-1212 with ID 615-253-385# and Passcode 1674609.

Will a recording of the CannaPharmaRx investor conference call be available?

Yes, a recording of the call will be available upon request.

What is the stock symbol for CannaPharmaRx?

The stock symbol for CannaPharmaRx is CPMD.